Engineering human microbiota for disease prevention and therapy
dc.contributor.author | Vangelista, L. | |
dc.date.accessioned | 2017-09-20T09:25:29Z | |
dc.date.available | 2017-09-20T09:25:29Z | |
dc.date.issued | 2017-09-15 | |
dc.identifier.citation | Vangelista, L. (2017) Engineering human microbiota for disease prevention and therapy. National Laboratory Astana, Nazarbayev University | ru_RU |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/2674 | |
dc.language.iso | en | ru_RU |
dc.publisher | National Laboratory Astana, Nazarbayev University | ru_RU |
dc.rights | Open Access - the content is available to the general public | ru_RU |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.subject | Commensal bacteria | ru_RU |
dc.subject | vaccine | ru_RU |
dc.subject | therapy | ru_RU |
dc.subject | microbicide | ru_RU |
dc.subject | HIV | ru_RU |
dc.subject | CCL5 | ru_RU |
dc.subject | CCR5 | ru_RU |
dc.title | Engineering human microbiota for disease prevention and therapy | ru_RU |
dc.type | Abstract | ru_RU |